OTC Markets OTCPK - Delayed Quote USD

Sinopharm Group Co. Ltd. (SHTDF)

Compare
1.9700 0.0000 (0.00%)
At close: October 10 at 4:00 PM EDT
Loading Chart for SHTDF
DELL
  • Previous Close 0.0000
  • Open 2.5000
  • Bid 2.5000 x 40000
  • Ask 3.2000 x 40000
  • Day's Range 2.5000 - 2.5000
  • 52 Week Range 1.9700 - 2.9500
  • Volume 200
  • Avg. Volume 3,954
  • Market Cap (intraday) 8.371B
  • Beta (5Y Monthly) 0.88
  • PE Ratio (TTM) 5.05
  • EPS (TTM) 0.3900
  • Earnings Date Oct 25, 2024 - Oct 29, 2024
  • Forward Dividend & Yield 0.12 (6.23%)
  • Ex-Dividend Date Jun 17, 2024
  • 1y Target Est --

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

www.sinopharmgroup.com.cn

113,635

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SHTDF

View More

Performance Overview: SHTDF

Trailing total returns as of 10/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHTDF
17.14%
HANG SENG INDEX
24.66%

1-Year Return

SHTDF
27.61%
HANG SENG INDEX
21.32%

3-Year Return

SHTDF
16.40%
HANG SENG INDEX
14.44%

5-Year Return

SHTDF
24.50%
HANG SENG INDEX
17.25%

Compare To: SHTDF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHTDF

View More

Valuation Measures

Annual
As of 10/10/2024
  • Market Cap

    8.37B

  • Enterprise Value

    16.52B

  • Trailing P/E

    5.02

  • Forward P/E

    5.89

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.07

  • Price/Book (mrq)

    0.57

  • Enterprise Value/Revenue

    0.20

  • Enterprise Value/EBITDA

    4.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.47%

  • Return on Assets (ttm)

    3.08%

  • Return on Equity (ttm)

    11.90%

  • Revenue (ttm)

    590.35B

  • Net Income Avi to Common (ttm)

    8.65B

  • Diluted EPS (ttm)

    0.3900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.33B

  • Total Debt/Equity (mrq)

    82.54%

  • Levered Free Cash Flow (ttm)

    8.82B

Company Insights: SHTDF

People Also Watch